CpG oligodeoxynucleotide enhances immunity against blood-stage malaria infection in mice parenterally immunized with a yeast-expressed 19 kDa carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein-1 (MSP119) formulated in oil-based Montanides

This publication has 33 references indexed in Scilit:

• Improved Immunogenicity and Efficacy of the Recombinant 19-Kilodalton Merozoite Surface Protein 1 by the Addition of Oligodeoxynucleotide and Aluminum Hydroxide Gel in a Murine Malaria Vaccine Model
  Infection and Immunity, 2002
• Intranasal immunization with yeast‐expressed 19 kD carboxyl‐terminal fragment of Plasmodium yoelii merozoite surface protein‐1 (yMSP1₁₉) induces protective immunity to blood stage malaria infection in mice
  Parasite Immunology, 1998
• Definition of T cell epitopes within the 19 kDa carboxylterminal fragment of Plasmodium yoelii merozoite surface protein 1 (MSP1₁₉) and their role in immunity to malaria
  Parasite Immunology, 1998
• Phase I trial in humans of an oil-based adjuvant SEPPIC MONTANIDE ISA 720
  Vaccine, 1997
• CpG motifs in bacterial DNA trigger direct B-cell activation
  Nature, 1995
• Immunization against malaria with a recombinant protein
  Parasite Immunology, 1994
• A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies.
  The Journal of Experimental Medicine, 1990
• CpG islands as gene markers in the vertebrate nucleus
  Trends in Genetics, 1987
• Interferon-γ and B Cell Stimulatory Factor-1 Reciprocally Regulate Ig Isotype Production
  Science, 1987
• Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
  Proceedings of the National Academy of Sciences, 1979